Medtronic Income Statement

MDT / Health Care|15 years of annual SEC 10-K data (FY2012-FY2026)

Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.

Medtronic reported $32.4B in revenue and $3.7B in net income for FY2026. Revenue has grown at a 4.9% compound annual rate over the past 14 years.

Based on SEC 10-K filings.

Item	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012
Revenue	$32.4B	$31.2B	$33.5B	$30.1B	$28.9B	$30.6B	$30.1B	$28.9B	$30.6B	$30.0B	$29.7B	$28.8B	$20.3B	$17.0B	$16.6B
Cost of Revenue	$11.2B	$10.7B	$11.6B	$10.5B	$9.4B	$9.2B	$10.5B	$9.4B	$9.2B	$9.1B	$9.3B	$9.1B	$6.3B	$4.3B	$4.1B
Gross Profit	-	-	-	-	-	-	-	$5.3B	$5.2B	$5.0B	$20.4B	$19.7B	$14.0B	$12.7B	-
SG&A Expense	$10.7B	$10.4B	$10.8B	$10.1B	$10.1B	$10.4B	$10.1B	$10.1B	$10.4B	$10.2B	$10.0B	$9.5B	$6.9B	$5.8B	$5.7B
R&D Expense	$2.7B	$2.7B	$2.7B	$2.5B	$2.3B	$2.3B	$2.5B	$2.3B	$2.3B	$2.3B	$2.2B	$2.2B	$1.6B	$1.5B	$1.6B
Operating Income	$5.1B	$5.5B	$6.0B	$4.5B	$4.8B	$6.3B	$4.5B	$4.8B	$6.3B	$6.6B	$5.4B	$5.4B	$3.8B	$3.8B	$4.4B
Interest Expense	$597.0M	$386.0M	-	$925.0M	$1.1B	$1.4B	$925.0M	$1.1B	$1.4B	$1.1B	$1.1B	$1.4B	$666.0M	$379.0M	$388.0M
Income Tax	$1.1B	$1.6B	$936.0M	$265.0M	-$751.0M	$547.0M	$265.0M	-$751.0M	$547.0M	$2.6B	$578.0M	$798.0M	$811.0M	$640.0M	$784.0M
Net Income	$3.7B	$3.8B	$4.7B	$3.6B	$4.8B	$4.6B	$3.6B	$4.8B	$4.6B	$3.1B	$4.0B	$3.5B	$2.7B	$3.1B	$3.5B
EPS (Basic)	$2.77	$2.83	$3.75	$2.68	$3.57	$3.44	$2.29	$2.92	$2.51	$2.44	$3.06	$3.40	$2.44	$3.06	$3.40
EPS (Diluted)	$2.76	$2.82	$3.73	$2.66	$3.54	$3.41	$2.27	$2.89	$2.48	$2.41	$3.02	$3.37	$2.41	$3.02	$3.37
Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.4B	1.4B	1.4B	1.4B	999.0M	1.1B	1.0B	1.0B
Gross Margin	-	-	-	-	-	-	-	18.3%	17.0%	16.8%	68.7%	68.3%	68.9%	74.5%	-
Operating Margin	15.9%	17.6%	17.8%	14.9%	16.6%	20.5%	14.9%	16.6%	20.5%	22.2%	18.1%	18.6%	18.6%	22.4%	26.5%
Profit Margin	11.4%	12.0%	13.9%	12.0%	16.6%	15.2%	12.0%	16.6%	15.2%	10.4%	13.6%	12.3%	13.2%	18.0%	20.9%

Other Financial Statements

Balance Sheet Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Medtronic Profile All Financial Data

Item

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Revenue

$32.4B

$31.2B

$33.5B

$30.1B

$28.9B

$30.6B

$30.1B

$28.9B

$30.6B

$30.0B

$29.7B

$28.8B

$20.3B

$17.0B

$16.6B

Cost of Revenue

$11.2B

$10.7B

$11.6B

$10.5B

$9.4B

$9.2B

$10.5B

$9.4B

$9.2B

$9.1B

$9.3B

$9.1B

$6.3B

$4.3B

$4.1B

Gross Profit

$5.3B

$5.2B

$5.0B

$20.4B

$19.7B

$14.0B

$12.7B

SG&A Expense

$10.7B

$10.4B

$10.8B

$10.1B

$10.4B

$10.1B

$10.4B

$10.2B

$10.0B

$9.5B

$6.9B

$5.8B

$5.7B

R&D Expense

$2.7B

$2.5B

$2.3B

$2.5B

$2.3B

$2.2B

$1.6B

$1.5B

$1.6B

Operating Income

$5.1B

$5.5B

$6.0B

$4.5B

$4.8B

$6.3B

$4.5B

$4.8B

$6.3B

$6.6B

$5.4B

$3.8B

$4.4B

Interest Expense

$597.0M

$386.0M

$925.0M

$1.1B

$1.4B

$925.0M

$1.1B

$1.4B

$1.1B

$1.4B

$666.0M

$379.0M

$388.0M

Income Tax

$1.1B

$1.6B

$936.0M

$265.0M

-$751.0M

$547.0M

$265.0M

-$751.0M

$547.0M

$2.6B

$578.0M

$798.0M

$811.0M

$640.0M

$784.0M

Net Income

$3.7B

$3.8B

$4.7B

$3.6B

$4.8B

$4.6B

$3.6B

$4.8B

$4.6B

$3.1B

$4.0B

$3.5B

$2.7B

$3.1B

$3.5B

EPS (Basic)

$2.77

$2.83

$3.75

$2.68

$3.57

$3.44

$2.29

$2.92

$2.51

$2.44

$3.06

$3.40

$2.44

$3.06

$3.40

EPS (Diluted)

$2.76

$2.82

$3.73

$2.66

$3.54

$3.41

$2.27

$2.89

$2.48

$2.41

$3.02

$3.37

$2.41

$3.02

$3.37

Shares Outstanding

1.3B

1.4B

999.0M

1.1B

1.0B

Gross Margin

18.3%

17.0%

16.8%

68.7%

68.3%

68.9%

74.5%

Operating Margin

15.9%

17.6%

17.8%

14.9%

16.6%

20.5%

14.9%

16.6%

20.5%

22.2%

18.1%

18.6%

22.4%

26.5%

Profit Margin

11.4%

12.0%

13.9%

12.0%

16.6%

15.2%

12.0%

16.6%

15.2%

10.4%

13.6%

12.3%

13.2%

18.0%

20.9%